Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1-10 of 26 for

  • Results filtered:
  • Study status: Open/Status Unknown
Edit search filters
  1. A Study to Evaluate GB002 in Adults with Pulmonary Arterial Hypertension (PAH)

    Jacksonville, FL, Rochester, MN

  2. Exercise Training to Improve Pulmonary Haemodynamic and Right Ventricular Function in Heart Failure Patients with Pulmonary Hypertension

    Jacksonville, FL

  3. A Study of Sotatercept for the Treatment of Cpc-PH Due to HFpEF (MK-7962-007/​A011-16)

    Jacksonville, FL

  4. A Study to Assess the Aria CV Pulmonary Hypertension System to Treat Pulmonary Arterial Hypertension

    Rochester, MN

  5. A Study of Rodatristat Ethyl in Patients With Pulmonary Arterial Hypertension (ELEVATE 2)

    Jacksonville, FL, Rochester, MN

  6. Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)

    Jacksonville, FL

  7. An Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan to Treat Patients with Pulmonary Arterial Hypertension

    Scottsdale/Phoenix, AZ

  8. A Study of AV-101 (Dry Powder Inhaled Imatinib) in Patients With Pulmonary Arterial Hypertension (PAH)

    Jacksonville, FL

  9. A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary Hypertension

    Rochester, MN

  10. Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study

    Rochester, MN

.

Mayo Clinic Footer